Theravance Biopharma TBPH Price / sales

Price / sales at other companies

Gyre Therapeutics, Inc.GYRE

6.2×-0.4×

Rigel PharmaceuticalsRIGL

1.7×+0.1×

LQD

Liquidia CorporationLQDA

11.5×-77.4×

Royalty PharmaRPRX

9.8×+3.2×

United TherapeuticsUTHR

7.3×+3.0×

Zevra Therapeutics, Inc.ZVRA

6.2×-1.8×

FAQ

What is Theravance Biopharma's price / sales?

Theravance Biopharma (TBPH) reported price / sales of 7.6× in Q1 2026.

How has Theravance Biopharma's price / sales changed year-over-year?

Theravance Biopharma's price / sales increased by 12.5% year-over-year, from 6.8× to 7.6×.

What is the long-term trend for Theravance Biopharma's price / sales?

Over 5 years (2020 to 2025), Theravance Biopharma's price / sales has grown at a -11.2% compound annual growth rate (CAGR), from 15.9× to 8.8×.

What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.